Nantahala Capital Management, LLC Lyra Therapeutics, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.55 Billion
- Q1 2024
A detailed history of Nantahala Capital Management, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 2,820,982 shares of LYRA stock, worth $733,455. This represents 1.13% of its overall portfolio holdings.
Number of Shares
2,820,982
Previous 4,050,218
30.35%
Holding current value
$733,455
Previous $21.2 Million
17.33%
% of portfolio
1.13%
Previous 1.43%
Shares
6 transactions
Others Institutions Holding LYRA
# of Institutions
82Shares Held
44.4MCall Options Held
300KPut Options Held
1.3K-
Perceptive Advisors LLC New York, NY12.8MShares$3.32 Million1.67% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.34MShares$1.13 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.78MShares$722,8675.45% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.74MShares$713,0390.04% of portfolio
-
Vr Adviser, LLC New York, NY2.58MShares$669,7841.38% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $8.27M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...